Search

everythinglearnresearchcommunity

for

Search:↓

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Increased 11β-HSD1 activity in skin may contribute to aging and could be targeted to reduce aging effects.

Acne not improved by usual treatments may indicate a genetic disorder.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Sebocytes play a key role in controlling androgen levels in human skin.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Measuring 24-OHase induction helps identify defects in vitamin D processing and predict treatment response.

Human hair follicles can process steroid hormones like DHEA.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

A new compound was made that might help treat diseases related to male hormones.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

17α-estradiol boosts aromatase activity in female hair follicles, potentially helping with hair loss.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Individuals with this condition often develop male traits and identities at puberty despite being raised as females.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.